Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China flag China · Delayed Price · Currency is CNY
83.14
-1.78 (-2.10%)
Sep 11, 2026, 3:00 PM CST

SHA:688016 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,4301,3501,2031,187896.5684.63
Other Revenue
-0.143.670.01--
1,4301,3511,2061,187896.5684.63
Revenue Growth
26.16%11.96%1.61%32.43%30.95%45.59%
Cost of Revenue
403.28399.84330.27285.93224.74154
Gross Profit
1,027950.79876.06901.27671.76530.63
Selling, General & Admin
298.85290.25250.25185.19150.02103.81
Research & Development
83.4567.7993.77172.88137.54102.27
Other Operating Expenses
-18.32-0.246.587.58.35.32
Operating Expenses
365.41366.1353.85366.91298.49212.68
Operating Income
661.47584.69522.21534.36373.27317.95
Interest Expense
-0.51-2.16-1.65-1.82-2.09-1.77
Interest & Investment Income
19.4426.9104.518.4115.3628.79
Currency Exchange Gain (Loss)
-9.09-4.471.591.192-0.44
Other Non Operating Income (Expenses)
-10.59-0.16-0.38-0.22-0.24-0.16
EBT Excluding Unusual Items
660.72604.8626.26551.92388.29344.38
Gain (Loss) on Sale of Investments
0.370.37----
Gain (Loss) on Sale of Assets
-0.1-0.09-0.7-0.1-0.23-
Asset Writedown
-5.85-----
Other Unusual Items
8.2148.426.6320.4425.8317.28
Pretax Income
663.34653.49652.19572.27413.9361.66
Income Tax Expense
101.7998.83159.4585.0561.8448.15
Earnings From Continuing Operations
561.55554.66492.75487.22352.05313.51
Minority Interest in Earnings
9.498.679.355.214.832.34
Net Income
571.04563.33502.1492.43356.88315.86
Net Income to Common
571.04563.33502.1492.43356.88315.86
Net Income Growth
38.19%12.19%1.96%37.98%12.99%47.17%
Shares Outstanding (Basic)
120121123108107107
Shares Outstanding (Diluted)
120121123108107107
Shares Change
-2.87%-1.80%14.50%0.50%0.00%-0.10%
EPS (Basic)
4.774.654.074.573.332.95
EPS (Diluted)
4.774.654.074.573.332.95
EPS Growth
42.28%14.25%-10.95%37.30%12.99%47.32%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
290.39270.03160.95368.0539.78210.67
Free Cash Flow Per Share
2.422.231.303.420.371.97
Dividend Per Share
1.0002.3002.0122.0131.5441.409
Dividend Growth
-39.39%14.31%-0.07%30.44%9.52%133.34%
Gross Margin
71.80%70.40%72.62%75.91%74.93%77.51%
Operating Margin
46.25%43.29%43.29%45.01%41.64%46.44%
Profit Margin
39.93%41.71%41.62%41.48%39.81%46.13%
Free Cash Flow Margin
20.30%19.99%13.34%31.00%4.44%30.77%
EBITDA
727.2648.06560.3558.39395.92333.41
EBITDA Margin
50.85%47.98%46.45%47.03%44.16%48.70%
D&A For EBITDA
65.7363.3838.124.0322.6515.46
EBIT
661.47584.69522.21534.36373.27317.95
EBIT Margin
46.25%43.29%43.29%45.01%41.64%46.44%
Effective Tax Rate
15.35%15.12%24.45%14.86%14.94%13.31%
Revenue as Reported
636.21,3511,2061,187896.5684.63